Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection

Author： Re M.C.   Monari P.   Bon I.   Borderi M.   Chiodo F.   HIV-1 Emilia Romagna Infectious Disease Study Group  

Publisher： Elsevier

ISSN： 0924-8579

Source： International Journal of Antimicrobial Agents, Vol.23, Iss.2, 2004-02, pp. : 164-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Raltegravir: In Treatment-Naive Patients with HIV-1 Infection

By Croxtall Jamie D.   Scott Lesley J.  

Drugs, Vol. 70, Iss. 5, 2010-03 ,pp. : 631-642

Adis International

Access to resources Recommend Favorite

A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate

By Clercq Erik De  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2935-2937

Informa Healthcare

Access to resources Recommend Favorite

Cross-Study Analysis of the Relative Efficacies of Oral Antiviral Therapies for Chronic Hepatitis B Infection in Nucleoside-Naive Patients

By Dienstag Jules L.  

Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. : 35-49

Adis International

Access to resources Recommend Favorite

Mutations Associated with Anthelmintic Drug Resistance

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 9, Iss. 3, 2010-07 ,pp. : 105-112

Bentham Science Publishers

Access to resources Recommend Favorite

Mathematical Approaches in the Study of Viral Kinetics and Drug Resistance in HIV-1 Infection

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 329-344

Bentham Science Publishers

Access to resources Recommend Favorite